Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 2/20 | 0.53 |
| ▸ | ARG2 | P78540 | 4/20 | 0.48 |
| ▸ | ARG1 | P05089 | 3/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | EYA2 | O00167 | 1/20 | 0.48 |
| ▸ | APP | P05067 | 1/20 | 0.48 |
| ▸ | ACE | P12821 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.47 |
| ▸ | GRM8 | O00222 | 1/20 | 0.47 |
| ▸ | GRM6 | O15303 | 1/20 | 0.47 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.47 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.47 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.47 |
| ▸ | GRM5 | P41594 | 1/20 | 0.47 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.47 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.47 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.47 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.47 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.47 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL158633 | 1.00 | GSR (0.53) | GSRARG2ARG1TDP1EYA2 | |
| Water SCHEMBL1336386 | 0.98 | GSR (0.52) | GSRARG2ARG1TDP1EYA2 | |
| SCHEMBL10088294 | 0.98 | GSR (0.52) | GSRARG2ARG1TDP1EYA2 | |
| SCHEMBL7166178 | 0.98 | GSR (0.52) | GSRARG2ARG1TDP1EYA2 | |
| SCHEMBL5613110 | 0.96 | TDP1 (0.50) | GSRARG2ARG1TDP1EYA2 | |
| SCHEMBL10088295 | 0.94 | NOS2 (0.51) | GSRARG2ARG1TDP1EYA2 | |
| SCHEMBL17690553 | 0.92 | GSR (0.46) | GSRARG2ARG1TDP1EYA2 | |
| SCHEMBL13233386 | 0.90 | GSR (0.47) | GSRARG2ARG1CYP1A2GRM8 | |
| SCHEMBL11579726 | 0.86 | GSR (0.55) | GSRARG2ARG1CYP1A2GRM8 | |
| Edetic Acid SCHEMBL30301418 | 0.86 | GSR (0.67) | GSRARG2ARG1TDP1EYA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4259099-A1 | BIOLOGICAL DELIVERY SYSTEMS | Particella, Inc. (US) | 2023-10-18 | — | — | EP | claimed |
| US-20230181466-A1 | BOTTOM-UP ASSEMBLY OF SYNTHETIC EXTRACELLULAR VESICLES | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2023-06-15 | — | — | US | claimed |
| WO-2022132678-A1 | BIOLOGICAL DELIVERY SYSTEMS | DNALITE THERAPEUTICS, INC. (US) | 2022-06-23 | — | — | WO | claimed |
| EP-3277845-A1 | BEADS FOR NUCLEIC ACID SEQUENCING | Genapsys Inc. (US) | 2018-02-07 | — | — | EP | claimed |
| WO-2016160475-A1 | BEADS FOR NUCLEIC ACID SEQUENCING | GENAPSYS, INC. (US) | 2016-10-06 | — | — | WO | claimed |
| EP-1817582-A2 | POLYMER-COATED SUBSTRATES FOR BINDING BIOMOLECULES AND METHODS OF MAKING AND USING THEREOF | Corning Incorporated (US) | 2007-08-15 | — | — | EP | claimed |
| WO-2006058237-A2 | POLYMER-COATED SUBSTRATES FOR BINDING BIOMOLECULES AND METHODS OF MAKING AND USING THEREOF | CORNING INCORPORATED (US) | 2006-06-01 | — | — | WO | claimed |
| EP-1011730-A2 | TARGETED ADDITION OF SOLUBLE POLYMERS TO RECOMBINANT PROTEINS | Edge Biosystems, Inc. (US) | 2000-06-28 | — | — | EP | claimed |
| WO-1998015293-A2 | TARGETED ADDITION OF SOLUBLE POLYMERS TO RECOMBINANT PROTEINS | EDGE BIOSYSTEMS, INC. (US) | 1998-04-16 | — | — | WO | claimed |
| US-12569439-B2 | Bottom-up assembly of synthetic extracellular vesicles | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2026-03-10 | — | — | US | disclosed |
| EP-4356134-A1 | METHOD FOR IMMUNOSENSING ON A LIPID LAYER USING MAGNETIC TUNNEL JUNCTIONS | Roche Diagnostics GmbH (DE) | 2024-04-24 | — | — | EP | disclosed |
| EP-4356132-A1 | METHOD FOR IMMUNOSENSING ON A LIPID LAYER | F. Hoffmann-La Roche AG (CH) | 2024-04-24 | — | — | EP | disclosed |
| EP-4259099-A1 | BIOLOGICAL DELIVERY SYSTEMS | Particella, Inc. (US) | 2023-10-18 | — | — | EP | disclosed |
| US-20230181466-A1 | BOTTOM-UP ASSEMBLY OF SYNTHETIC EXTRACELLULAR VESICLES | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2023-06-15 | — | — | US | disclosed |
| WO-1999018238-A1 | COMBINATORIAL ANTISENSE LIBRARY | OASIS BIOSCIENCES, INC. (US) | 1999-04-15 | — | — | WO | disclosed |
| WO-1998056906-A1 | TRIMERISING MODULE | THOEGERSEN HANS CHRISTIAN (DK) | 1998-12-17 | — | — | WO | disclosed |
| WO-1998031839-A2 | ELECTRONIC-PROPERTY PROBING OF BIOLOGICAL MOLECULES AT SURFACES | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1998-07-23 | — | — | WO | disclosed |
| WO-1998015293-A2 | TARGETED ADDITION OF SOLUBLE POLYMERS TO RECOMBINANT PROTEINS | EDGE BIOSYSTEMS, INC. (US) | 1998-04-16 | — | — | WO | disclosed |
| EP-0686162-A1 | IMPROVED METHOD FOR THE REFOLDING OF PROTEINS | DENZYME APS (DK) | 1995-12-13 | — | — | EP | disclosed |
| WO-1994018227-A2 | IMPROVED METHOD FOR THE REFOLDING OF PROTEINS | DENZYME APS (DK) | 1994-08-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12569439-B2 | Bottom-up assembly of synthetic extracellular vesicles | EXOSC10, PLTP, EXOSC9 | GSR 4404/4885ARG2 3036/4885ARG1 2426/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.